联合不可逆转的四环素破坏酶抑制剂
Ruihao Li1, Yao-Peng Xue2, Steven T Le1
1Department of Chemistry, Washington University in St. Louis, St. Louis, Missouri 63130-4899, United States.
ACS infectious diseases
|August 30, 2025
概括
研究人员开发了针对四环素破坏酶 (TDases) 的新型共价抑制剂,这些酶导致抗生素耐药性. 这些抑制剂成功地恢复了耐药细菌的四环素活性,为抗酶失活提供了有前途的策略.
科学领域:
- 医学化学
- 生物化学
- 微生物学
背景情况:
- 抗生素耐药性对全球健康构成重大威胁,
- 环素破坏酶 (TDases),同类于黄素单氧酶,是新兴的酶,可以使环素抗生素失活.
- 开发这些耐药性酶的抑制剂对于对抗细菌耐药性的联合疗法至关重要.
研究的目的:
- 设计,合成和描述第一个共价不可逆的TDase抑制剂.
- 探索抑制机制并评估它们在恢复抗生素活性方面的有效性.
主要方法:
- 含有反应性弹头的无水甲素 (aTC) 衍生物的化学合成 (曼尼克反应).
- 对1型 (TetX6,TetX7) 和2型 (Tet50) TDases的抑制作用和机制的生物化学特征.
- 使用非特异性弗拉单氧酶抑制剂和质谱测试以探测FAD辅因子相互作用的机制研究.
- 在体外评估抑制剂在恢复对抗耐药性大肠杆菌的活性.
主要成果:
- 合成了基于aTC的新型共价抑制剂 (化合物3 - 5) 并证明了1型和2型TDase的强烈抑制.
- 2型TDases的抑制是时间依赖的和不可逆转的,与蓝光增强的FAD辅因子的共价修饰一致.
- 在低度 (2微克/毫升) 中,抑制剂成功恢复了对*大肠杆菌*过度表达的TDase的活性.
结论:
- 通过FAD辅因子捕获对TDases的共价抑制是一种克服抗生素耐药性的可行策略.
- 开发的抑制剂代表了对抗耐药细菌感染的组合治疗的有前途的新疗法.
- 了解不同类型的TDase抑制机制可以指导未来的药物设计.
更多相关视频
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
9.4K
08:30A Complete Method for Evaluating the Performance of Photocatalysts for the Degradation of Antibiotics in Environmental Remediation
Published on: October 6, 2022
2.3K
相关概念视频
Eukaryotic Transcription Inhibitors
10.0K
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.0K
The Electron Transport Chain
17.3K
The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
17.3K
Enzyme Inhibition
79.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
79.5K
Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drug-Receptor Bonds
3.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
3.2K
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
